Nicklaus Children's Hospital's Heart Institute Offers the Minima Stent
Kalin Ned — September 1, 2025 — Life-Stages
References: nicklauschildrens.org
Nicklaus Children's Hospital's Heart Institute has become the inaugural medical facility in South Florida to provide a novel cardiac stent, known as the Minima Stent. This device, which has recently received approval from the U.S. Food and Drug Administration, is specifically engineered for pediatric use. It features a unique capacity for controlled expansion to accommodate a child's physical development, thereby addressing a significant limitation of existing stents that are designed for adult anatomy and cannot be adjusted as readily.
The Minima Stent technology is intended to treat congenital conditions such as coarctation of the aorta and branch pulmonary stenosis, with the primary clinical benefit being a substantial reduction in the number of invasive open-heart procedures a patient would otherwise require throughout childhood and adolescence.
The hospital's cardiology team played a collaborative role in the development of this stent alongside its manufacturer, Renata Medical, and its implementation is characterized as a major advancement within the specialized field of pediatric interventional cardiology.
Image Credit: Nicklaus Children's Hospital
The Minima Stent technology is intended to treat congenital conditions such as coarctation of the aorta and branch pulmonary stenosis, with the primary clinical benefit being a substantial reduction in the number of invasive open-heart procedures a patient would otherwise require throughout childhood and adolescence.
The hospital's cardiology team played a collaborative role in the development of this stent alongside its manufacturer, Renata Medical, and its implementation is characterized as a major advancement within the specialized field of pediatric interventional cardiology.
Image Credit: Nicklaus Children's Hospital
Trend Themes
-
Pediatric-specific Medical Devices — The development of medical devices like the Minima Stent tailored for pediatric use opens new possibilities for less invasive and more adaptable treatment options for children.
-
Expandable Biomedical Technology — Biomedical innovations featuring flexible expansion capabilities address the evolving needs of growing patients, enhancing the longevity and effectiveness of medical treatments.
-
Collaborative Healthcare Innovations — Partnerships between healthcare institutions and manufacturers facilitate breakthroughs in specialized medical fields, optimizing the design and application of innovative health solutions.
Industry Implications
-
Pediatric Healthcare — The introduction of pediatric-specific technologies such as the Minima Stent revolutionizes patient care by addressing the unique physiological needs of children.
-
Biomedical Engineering — Advancements in engineering, like the expansion capability of the Minima Stent, drive innovation in creating adaptable medical devices for specialized patient demographics.
-
Medical Device Manufacturing — Collaborations in medical device manufacturing lead to the production of groundbreaking technologies, enhancing treatment options and patient outcomes across various healthcare sectors.
7.3
Score
Popularity
Activity
Freshness
